Patrick Baeuerle

Executive Partner at MPM Capital Inc

Patrick Baeuerle

Patrick Baeuerle

Executive Partner at MPM Capital Inc

Overview

Career Highlights

Cullinan Oncology LLC
iOmx Therapeutics AG
TCR2 Therapeutics, Inc.

RelSci Relationships

2430

Number of Boards

9

Birthday

1958

Age

63

Relationships

View Relationship Details

RelSci Relationships are individuals Patrick Baeuerle likely has professional access to. A relationship does not necessarily indicate a personal connection.

Ansbert Gadicke

Co-Founder at MPM Capital Inc

Relationship likelihood: Strong

Luke Evnin

Co-Founder at MPM Capital Inc

Relationship likelihood: Strong

Owen Hughes

Executive Partner at MPM Capital Inc

Relationship likelihood: Strong

Morana Jovan-Embiricos

Founder at F2 Capital Ventures LLP

Relationship likelihood: Strong

Daniel J. Hicklin

Executive Partner at MPM Capital Inc

Relationship likelihood: Strong

Mitchell Finer

Executive Partner at MPM Capital Inc

Relationship likelihood: Strong

Briggs Morrison

Executive Partner at MPM Capital Inc

Relationship likelihood: Strong

Gary E. Menzel

Director, President & Chief Executive Officer at TCR2 Therapeutics, Inc.

Relationship likelihood: Strong

Kristen Laguerre

Chief Financial Officer & Chief Operating Officer at MPM Capital Inc

Relationship likelihood: Strong

Leigh Zawel

Executive Partner at MPM Capital Inc

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

PR Newswire

August 25, 2020

iOmx Therapeutics Enhances Supervisory Board; Gerald Moeller, Ph.D., Elected Chairman of Supervisory Board; Rainer Strohmenger, MD, and Shinichiro Fuse, Ph.D., Named Supervisory Board Members

FierceBiotech

July 27, 2020

TCR2's T-cell therapy curbs solid tumors in early phase 1 readout

Business Wire

July 22, 2020

Cullinan Oncology Launches Cullinan Amber to Pioneer Next-Generation Cytokine Fusion Proteins for Cancer Therapy

RelSci

July 3, 2020

Patrick Baeuerle is no longer serving in their board position at Harpoon Therapeutics, Inc.

ENP Newswire

July 3, 2020

-Harpoon Therapeutics Announces Changes to Board of Directors

Paths to Patrick Baeuerle

Potential Connections via
Relationship Science

You

Patrick Baeuerle

Executive Partner at MPM Capital Inc

Education

Doctorate Degree

Ludwig Maximilian University of Munich

Ludwig-Maximilians-Universität München is a premier academic and research institutions.

Doctorate Degree

Max-Planck-Institute for Molecular Genetics

The Max Planck Institute of Molecular Genetics Berlin focuses on research in the fields of molecular genetics.

Memberships

Member

Current

European Molecular Biology Organization

Career History

Co-Founder

2016 - Current

Cullinan Oncology LLC

Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Chief Scientific Officer-Biologics

2016 - Current

Cullinan Management, Inc.

Cullinan Management, Inc. is a biopharmaceutical company engages in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on 15 September, 2016 and is headquartered in Cambridge, MA.

Co-Founder

2016 - Current

iOmx Therapeutics AG

iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany.

Boards & Committees

Member, Board of Directors

Prior

F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Member, Board of Directors

Prior

Tularik, Inc.

Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA.

Investments

Details Hidden

Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc. engages in the development of treatment for cancer. It offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin and Luke B. Evnin and is headquartered in Cambridge, MA.

Details Hidden

iOmx Therapeutics AG

iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany.

Details Hidden

Cullinan Oncology LLC

Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Public Holdings

Restricted data only for RelSci Professional users.

Other Affiliations

Patrick Baeuerle is affiliated with Cullinan Oncology LLC, Cullinan Management, Inc., iOmx Therapeutics AG, TCR2 Therapeutics, Inc., MPM Capital Inc, Maverick Therapeutics, Inc., Harpoon Therapeutics, Inc., Amgen Research (Munich) GmbH, Amgen Rockville, Inc., F. Hoffmann-La Roche Ltd., Micromet AG, Tularik, Inc., University of Freiburg, Werewolf Therapeutics, Inc., F. Hoffmann-La Roche Ltd., Tularik, Inc.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Patrick Baeuerle. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Patrick Baeuerle's profile does not indicate a business or promotional relationship of any kind between RelSci and Patrick Baeuerle.